Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/complementary-roles-of-tumour-specific-pet-tracer-18f-famt-to-18f-fdg-Cyq3LSWAJ2
References (48)
-
R. Fujimoto, T. Higashi, Y. Nakamoto, T. Hara, A. Lyshchik, K. Ishizu, H. Kawashima, S. Kawase, T. Fujita, T. Saga, K. Togashi (2006)
Diagnostic accuracy of bone metastases detection in cancer patients: Comparison between bone scintigraphy and whole-body FDG-PETAnnals of Nuclear Medicine, 20
-
E. Even-Sapir, U. Metser, E. Mishani, Gennady Lievshitz, H. Lerman, I. Leibovitch (2006)
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 47 2
-
H. Schirrmeister, A. Buck, A. Guhlmann, S. Reske (2001)
Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography.Thyroid : official journal of the American Thyroid Association, 11 7
-
XH Qu, XL Huang, WL Yan, LM Wu, KR Dai (2012)
A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancerEur J Radiol, 81
-
Xianbo Peng, W. Guo, T. Ren, Zhiyuan Lou, Xin‐chang Lu, Shuai Zhang, Qun-shan Lu, Yifeng Sun (2013)
Differential Expression of the RANKL/RANK/OPG System Is Associated with Bone Metastasis in Human Non-Small Cell Lung CancerPLoS ONE, 8
-
Hideomi Watanabe, T. Shinozaki, T. Yanagawa, J. Aoki, M. Tokunaga, Tomio Inoue, K. Endo, S. Mohara, K. Sano, K. Takagishi (2000)
Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning.The Journal of bone and joint surgery. British volume, 82 5
-
K. Kaira, N. Oriuchi, Y. Otani, K. Shimizu, Shigebumi Tanaka, H. Imai, N. Yanagitani, N. Sunaga, T. Hisada, T. Ishizuka, K. Dobashi, Y. Kanai, H. Endou, T. Nakajima, K. Endo, M. Mori (2007)
Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic StudyClinical Cancer Research, 13
-
A Stecco, M Lombardi, L Leva, M Brambilla, E Negru, S Delli Passeri (2013)
Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastasesRadiol Med, 118
-
S Chatterjee, J Frew, J Mott, H McCallum, P Stevenson, R Maxwell (2012)
Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN studyClin Oncol (R Coll Radiol)., 24
-
(2005)
Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer -
P. Mürtz, C. Krautmacher, F. Träber, J. Gieseke, H. Schild, W. Willinek (2007)
Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 TeslaEuropean Radiology, 17
-
H. Schirrmeister, G. Glatting, J. Hetzel, K. Nüssle, Coskun Arslandemir, A. Buck, Kerstin Dziuk, A. Gabelmann, S. Reske, M. Hetzel (2001)
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42 12
-
Y. Kanai, H. Segawa, K. Miyamoto, H. Uchino, E. Takeda, H. Endou (1998)
Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)*The Journal of Biological Chemistry, 273
-
N. Sato, Tomio Inoue, Katsumi Tomiyoshi, Jun Aoki, N. Oriuchi, Ayako Takahashi, T. Otani, H. Kurihara, Tomio Sasaki, K. Endo (2003)
Gliomatosis cerebri evaluated by 18Fα-methyl tyrosine positron-emission tomographyNeuroradiology, 45
-
Hideomi Watanabe, Tomio Inoue, T. Shinozaki, T. Yanagawa, A. Ahmed, K. Tomiyoshi, N. Oriuchi, M. Tokunaga, J. Aoki, K. Endo, K. Takagishi (2000)
PET imaging of musculoskeletal tumours with fluorine-18 α-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PETEuropean Journal of Nuclear Medicine, 27
-
S. Chatterjee, J. Frew, J. Mott, H. Mccallum, P. Stevenson, Ross Maxwell, John Wilsdon, C. Kelly (2012)
Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapClinical oncology (Royal College of Radiologists (Great Britain)), 24 10
-
T. Inoue, K. Tomiyoshi, T. Higuichi, K. Ahmed, M. Sarwar, K. Aoyagi, S. Amano, S. Alyafei, H. Zhang, K. Endo (1998)
Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 39 4
-
K. Kaira, N. Oriuchi, H. Imai, K. Shimizu, N. Yanagitani, N. Sunaga, T. Hisada, T. Ishizuka, Y. Kanai, T. Nakajima, M. Mori (2009)
Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.Lung cancer, 66 1
-
Tomio Inoue, T. Shibasaki, N. Oriuchi, K. Aoyagi, K. Tomiyoshi, S. Amano, M. Mikuni, I. Ida, J. Aoki, K. Endo (1999)
18F α-methyl tyrosine PET studies in patients with brain tumorsThe Journal of Nuclear Medicine, 40
-
M. Mackiewicz-Wysocka, M. Pankowska, P. Wysocki (2012)
Progress in the treatment of bone metastases in cancer patientsExpert Opinion on Investigational Drugs, 21
-
O. Yanagida, Y. Kanai, Y. Kanai, A. Chairoungdua, Do Kim, H. Segawa, H. Segawa, T. Nii, S. Cha, H. Matsuo, H. Matsuo, Jun-ichi Fukushima, Yoshiki Fukasawa, Yoshiko Tani, Y. Taketani, H. Uchino, H. Uchino, Ju Kim, J. Inatomi, I. Okayasu, K. Miyamoto, E. Takeda, T. Goya, H. Endou (2001)
Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.Biochimica et biophysica acta, 1514 2
-
C. Costelloe, W. Murphy, B. Chasen (2009)
Musculoskeletal pitfalls in 18F-FDG PET/CT: pictorial review.AJR. American journal of roentgenology, 193 3 Suppl
-
B. Goudarzi, R. Kishimoto, Shuhei Komatsu, H. Ishikawa, K. Yoshikawa, S. Kandatsu, T. Obata (2010)
Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy.Magnetic resonance imaging, 28 3
-
Go Miyashita, T. Higuchi, N. Oriuchi, Y. Arisaka, H. Hanaoka, H. Tominaga, S. Morita, Mitsuyuki Miyakubo, T. Ishikita, Yoshiki Nakasone, A. Negishi, S. Yokoo, K. Endo (2010)
18F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with 18F-FDG PET and immunohistochemistryAnnals of Nuclear Medicine, 24
-
J. Lucas, Michael O'Doherty, J. Wong, J. Bingham, P. Mckee, C. Fletcher, M. Smith (1998)
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.The Journal of bone and joint surgery. British volume, 80 3
-
H. Christensen (1990)
Role of amino acid transport and countertransport in nutrition and metabolism.Physiological reviews, 70 1
-
Fanlin Kong, David Yang (2012)
Amino Acid transporter-targeted radiotracers for molecular imaging in oncology.Current medicinal chemistry, 19 20
-
K. Tomiyoshi, K. Amed, S. Muhammad, T. Higuchi, Tomio Inoue, K. Endo, David Yang (1997)
Synthesis of isomers of 18F‐labelled amino acid radiopharmaceutical: Position 2− and 3‐L‐18F-α‐methyltyrosine using a separation and purification systemNuclear Medicine Communications, 18
-
W. Hsu, Thomas Hearty (2012)
Radionuclide Imaging in the Diagnosis and Management of Orthopaedic DiseaseJournal of the American Academy of Orthopaedic Surgeons, 20
-
Mitsuyuki Miyakubo, N. Oriuchi, Y. Tsushima, T. Higuchi, K. Koyama, K. Arai, Bishnuhari Paudyal, Y. Iida, H. Hanaoka, T. Ishikita, Yoshiki Nakasone, A. Negishi, K. Mogi, K. Endo (2007)
Diagnosis of maxillofacial tumor withl-3-[18F]-fluoro-α-methyltyrosine (FMT) PET: a comparative study with FDG-PETAnnals of Nuclear Medicine, 21
-
T. Hamaoka, J. Madewell, D. Podoloff, G. Hortobagyi, N. Ueno (2004)
Bone imaging in metastatic breast cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 14
-
A. Stecco, M. Lombardi, L. Leva, M. Brambilla, E. Negru, S. Passeri, A. Carriero (2013)
Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastasesLa radiologia medica, 118
-
R. Rosen, L. Fayad, R. Wahl (2006)
Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 47 8
-
T. Inoue, K. Koyama, N. Oriuchi, S. Alyafei, Z. Yuan, H. Suzuki, K. Takeuchi, Y. Tomaru, K. Tomiyoshi, J. Aoki, K. Endo (2001)
Detection of malignant tumors: whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG--preliminary study.Radiology, 220 1
-
H. Daldrup-Link, C. Franzius, T. Link, Daniela Laukamp, J. Sciuk, H. Jürgens, O. Schober, E. Rummeny (2001)
Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.AJR. American journal of roentgenology, 177 1
-
K. Kaira, N. Oriuchi, K. Shimizu, T. Ishikita, T. Higuchi, H. Imai, N. Yanagitani, N. Sunaga, T. Hisada, T. Ishizuka, Y. Kanai, H. Endou, T. Nakajima, K. Endo, M. Mori (2009)
Correlation of angiogenesis with 18F‐FMT and 18F‐FDG uptake in non‐small cell lung cancerCancer Science, 100
-
J. McGivan, Marai PASTOR-ANGLADA (1994)
Regulatory and molecular aspects of mammalian amino acid transport.The Biochemical journal, 299 ( Pt 2)
-
Mitsuyuki Miyakubo, N. Oriuchi, Y. Tsushima, T. Higuchi, K. Koyama, K. Arai, Bishnuhari Paudyal, Y. Iida, H. Hanaoka, T. Ishikita, Yoshiki Nakasone, A. Negishi, K. Mogi, K. Endo (2007)
Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET.Annals of nuclear medicine, 21 2
-
Frederick Grant, F. Fahey, A. Packard, Royal Davis, A. Alavi, S. Treves (2007)
Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer*Journal of Nuclear Medicine, 49
-
F. Bray, A. Jemal, N. Grey, J. Ferlay, D. Forman (2012)
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.The Lancet. Oncology, 13 8
-
Hsiang-Hsuan Yu, Ya-Yu Tsai, Sarah Hoffe (2012)
Overview of diagnosis and management of metastatic disease to bone.Cancer control : journal of the Moffitt Cancer Center, 19 2
-
N. Ghanem, Markus Uhl, Ingo Brink, O. Schäfer, T. Kelly, Ernst Moser, Mathias Langer (2005)
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.European journal of radiology, 55 1
-
Pattama Wiriyasermkul, S. Nagamori, H. Tominaga, N. Oriuchi, K. Kaira, Hidekazu Nakao, Takeru Kitashoji, Ryuichi Ohgaki, Hidekazu Tanaka, H. Endou, K. Endo, H. Sakurai, Y. Kanai (2012)
Transport of 3-Fluoro-l-α-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PETThe Journal of Nuclear Medicine, 53
-
H. Schirrmeister, A. Guhlmann, K. Elsner, J. Kotzerke, G. Glatting, Mary Rentschler, B. Neumaier, Harald Trager, Naumann Karin, S. Reske (1999)
Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 40 10
-
D. Oxender, H. Christensen (1963)
Evidence for two Types of Mediation of Neutral Amino-Acid Transport in Ehrlich CellsNature, 197
-
H. Nawashiro, N. Otani, N. Shinomiya, S. Fukui, H. Ooigawa, K. Shima, H. Matsuo, Y. Kanai, H. Endou (2006)
L‐type amino acid transporter 1 as a potential molecular target in human astrocytic tumorsInternational Journal of Cancer, 119
-
Jean-Noël Talbot, F. Paycha, S. Balogova (2011)
Diagnosis of bone metastasis: recent comparative studies of imaging modalities.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 55 4
-
T. Inoue, T. Shibasaki, N. Oriuchi, K. Aoyagi, K. Tomiyoshi, S. Amano, M. Mikuni, I. Ida, J. Aoki, K. Endo (1999)
18F alpha-methyl tyrosine PET studies in patients with brain tumors.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 40 3
- Publisher
- Springer Journals
- Copyright
- Copyright © 2013 by Springer-Verlag Berlin Heidelberg
- Subject
- Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
- ISSN
- 1619-7070
- eISSN
- 1619-7089
- DOI
- 10.1007/s00259-013-2487-7
- pmid
- 24006150
- Publisher site
- See Article on Publisher Site
Abstract
The usefulness of 18 F-FAMT PET/CT for bone metastasis detection regardless of the lesion phenotype was demonstrated. The fact that 18 F-FAMT uptake was confirmed by 18 F-FDG uptake suggests that 18 F-FAMT PET/CT has the potential to complement 18 F-FDG PET/CT for the detection of bone metastases.
Journal
European Journal of Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Sep 5, 2013